Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
| Sales | 46 | 125 | 121,170 | 124 | 7 |
| Gross Profit | 40 | 120 | 120 | 353 | 7 |
| Operating Expenses | 1,410 | 1,570 | 1,590 | 1,670 | 1,410 |
| Operating Income | -1,364 | -1,445 | 119,580 | -1,546 | -1,403 |
| Interest Expense | 50 | 50 | 50 | 60 | 40 |
| Other Income | 104 | 115 | -120,980 | -11,684 | -7 |
| Pre-tax Income | -1,310 | -1,380 | -1,450 | -13,290 | -1,450 |
| Net Income Continuous | -1,318 | -1,384 | -1,457 | -13,280 | -1,455 |
| Net Income | $-1,318 | $-1,384 | $-1,457 | $-13,280 | $-1,455 |
| EPS Basic Total Ops | -327,832.20 | -327,832.20 | -327,832.20 | -3,212,736.00 | -327,832.20 |
| EPS Basic Continuous Ops | -327,832.20 | -327,832.20 | -327,832.20 | -3,212,736.00 | -327,832.20 |
| EPS Diluted Total Ops | -327,832.20 | -327,832.20 | -327,832.20 | -3,212,736.00 | -327,832.20 |
| EPS Diluted Continuous Ops | -327,832.20 | -327,832.20 | -327,832.20 | -3,212,736.00 | -327,832.20 |
| EBITDA(a) | $-1,334 | $-1,415 | $119,610 | $-1,526 | $-1,383 |